Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Hinderling

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1983
The pharmacokinetics of furazlocillin in healthy humansP H Hinderling, U Gundert-Remy, D Förster, et al.
Therapeutic Drug Monitoring|January 1, 1988
Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratioP H Hinderling, D Hartmann, C Crevoisier, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosisP H Hinderling, M Eckert, S Gasic, et al.
Journal of Clinical Pharmacology|July 1, 1995
Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteersP H Hinderling, A Tendolkar, C M Dee, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics of sematilide in renal failureJ Shi, E Ripley, T W Gehr, et al.
Clinical Pharmacology and Therapeutics|August 3, 1999
Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjectsJ T Barbey, M E Sale, R L Woosley, et al.
Therapeutic Drug Monitoring|April 11, 2001
Inhibition of thrombin by iopromide in vitroL L Graf, D A Young, D C Kressin, et al.
Therapeutic Drug Monitoring|February 1, 1997
Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patchL I Harrison, D J Riedel, S F Chang, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmiaJ P Saul, B Ross, M S Schaffer, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1983
The pharmacokinetics of furazlocillin in healthy humansP H Hinderling, U Gundert-Remy, D Förster, et al.
Therapeutic Drug Monitoring|January 1, 1988
Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratioP H Hinderling, D Hartmann, C Crevoisier, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosisP H Hinderling, M Eckert, S Gasic, et al.
Journal of Clinical Pharmacology|July 1, 1995
Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteersP H Hinderling, A Tendolkar, C M Dee, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics of sematilide in renal failureJ Shi, E Ripley, T W Gehr, et al.
Clinical Pharmacology and Therapeutics|August 3, 1999
Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjectsJ T Barbey, M E Sale, R L Woosley, et al.
Therapeutic Drug Monitoring|April 11, 2001
Inhibition of thrombin by iopromide in vitroL L Graf, D A Young, D C Kressin, et al.
Therapeutic Drug Monitoring|February 1, 1997
Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patchL I Harrison, D J Riedel, S F Chang, et al.
Clinical Pharmacology and Therapeutics|March 10, 2001
Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmiaJ P Saul, B Ross, M S Schaffer, et al.
Pageof 5